Jerome Wendoh Milimu1*†
Lauren Parmley1,†Mahlodi Matjeng1Mathata Madibane1Mandisi Mabika1Jacques Livingston1Joseph Lawrence1Orapeleng Motlhaoleng2Hasina Subedar2Rethabile Tsekoa1Zandile Mthembu1
- 1Bilateral Health Office, United States Agency for International Development, Pretoria, South Africa
- 2National Department of Health, South African Government, Pretoria, South Africa
A Corrigendum on
By Milimu JW, Parmley L, Matjeng M, Madibane M, Mabika M, Livington J, Lawrence J, Motlhaoleng O, Subedar H, Tsekoa R and Mthembu Z (2024). Front. Reprod. Health 6:1473354. doi: 10.3389/frph.2024.1473354
Text Correction
In the published article, there was an error. [“Specifically, in the introduction, there is a reference to the South African Health Products Regulatory Authority, which has been abbreviated twice as “SAPHRA.” However, the correct abbreviation is “SAHPRA.”].
A correction has been made to [Introduction], [Paragraph Numbers 69 & 81]. This sentence previously stated:
“[SAPHRA]”
The corrected sentence appears below:
“[SAHPRA]”
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Request to add ORCID identifiers for two authors
The first and second authors would like to request that their ORCiD identifiers be linked to the published article. The respective names and ORCiD identifiers are as shown below.
Jerome Wendoh Milimu (0000-0002-3383-2087)
Lauren Parmley (0000-0001-5119-5811)
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: HIV prevention, pre-exposure prophylaxis, PEPFAR program, South Africa, cabotegravir, dapivirine ring, lenacapavir, health systems strengthening
Citation: Milimu JW, Parmley L, Matjeng M, Madibane M, Mabika M, Livingston J, Lawrence J, Motlhaoleng O, Subedar H, Tsekoa R and Mthembu Z (2025) Corrigendum: Oral pre-exposure prophylaxis implementation in South Africa: a case study of USAID-supported programs. Front. Reprod. Health 7:1560111. doi: 10.3389/frph.2025.1560111
Received: 13 January 2025; Accepted: 14 January 2025;
Published: 24 January 2025.
Approved by: Frontiers In Reproductive Health, Frontiers Media SA, Switzerland
Copyright: © 2025 Milimu, Parmley, Matjeng, Madibane, Mabika, Livingston, Lawrence, Motlhaoleng, Subedar, Tsekoa and Mthembu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Jerome Wendoh Milimu, andlbmRvaEBnbWFpbC5jb20=
†ORCID:
Jerome Wendoh Milimu
orcid.org/0000-0002-3383-2087
Lauren Parmley
orcid.org/0000-0001-5119-5811